Description
Xpreza™ is a quality assured generic of Vidaza® (also known as Onureg®) used as a continued treatment for acute myeloid leukemia (AML) in adult patients who achieved first complete remission (CR) or CR with incomplete blood count recovery following intensive induction chemotherapy and are not able to complete intensive curative treatment. It’s produced in a US FDA approved factory in India.
Package Size : 14 Tablets
Active Ingredients : Azacitidine
Produced by Natco Pharma Ltd®